Search Results for Feinstein

festo robot zoo

No. 26: Schein on Stanley Bergman, killer weed for Wallkill and loud love in Brooklyn

TGIF: A good Friday everyone, and welcome to new readers. Don’t forget to send tips, news, story ideas, calendar items, releases, promotions, job postings, criticisms and corrections to editor@innovateli.com. ROOT FOR THE HOME TEAM: Students from Molloy College, Stony Brook University and Farmingdale State College will face off today in the state finals of the NY business plan competition, which includes 75 schools from 10 regions and $500,000 in prizes. Molloy College student Mike Russo earned top honors…


Traverse CEO Joseph Scaduto

Traverse readies the move to market

BY GREGORY ZELLER // Armed with a just-executed licensing agreement for a suite of anti-inflammatory drug therapies, two-year-old Traverse Biosciences is stepping up efforts to land the investors and strategic partners necessary for rapid product development. The licensing agreement with the SUNY Research Foundation gives Traverse rights to compounds developed by Stony Brook University faculty members Lorne Golub and Francis Johnson and known as — science alert — polyenolic zinc-binding agents. Their leading drug candidate,…


No. 25: Mission impossible, inside innovation and Googling Nessie

TGIW: A good Wednesday and welcome to our newest readers. This roundup is for you, so please tell us how we can make it better. Send tips, news, ideas, calendar items, releases, promotions, job postings, criticisms and corrections to editor@innovateli.com. OPINION MISSION LONG ISLAND: Gov. Andrew M. Cuomo was in Cuba this week to push his Global New York strategy, which seeks to expand trade and other business opportunities for Empire State companies. At his side: executives from…


CSHL's Bruce Stillman

North Shore-LIJ, CSHL in cancer partnership

Cold Spring Harbor Laboratory and North Shore-LIJ announced a joint cancer research and treatment effort that is designed to speed the region’s most-promising research to patients. The affiliation will better connect researchers at CSHL and North Shore’s Feinstein Institute for Medical Research and provide patients for clinical trials of the latest treatments, linking scieentists with more than 200 oncologists at North Shore-LIJ’s Cancer Institute. Cold Spring Harbor CEO Bruce Stillman called the paertnership a “transformative…


DepYMed CEO Andreas Grill

Clinical trials for DepYMed

A joint venture between biotech stalwart Ohr Pharmaceutical and Cold Spring Harbor Laboratory is taking the fight to breast cancer – though a revolutionary treatment may still be a half-decade away at least. Cold Spring Harbor-based DepYMed, which incorporated just 10 months ago, is eyeing the first clinical trials of an enzyme inhibitor the company is proffering as a potential breakthrough for patients with HER2-positive breast cancer – a cancer that causes uncontrolled amplification in…


Ryan, former Forest veep, named to CSHL post

Cold Spring Harbor Laboratory has added another major-league bat to its commercialization lineup. Charles Ryan, former senior vice president and chief intellectual property counsel at Forest Laboratories, is CSHL’s new general counsel, bringing a wealth of experience in patent law and partnering agreements to the cutting-edge R&D facility. “I’m very excited about this opportunity,” Ryan told Innovate-LI. “Long Island is an incredible place to do science and to do business, and there’s no place on…